Catalyst Wire Dossier Catalyst Wire Dossier

Licartin

Iodine-131 metaiodobenzylguanidine
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Licartin, covering 2016-04-01 to 2016-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of Licartin for Preventing Tumor Recurrence After Liver Resection [Phase 2]

See pricing